1. Home
  2. FOXF vs FBRX Comparison

FOXF vs FBRX Comparison

Compare FOXF & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$21.85

Market Cap

800.6M

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$76.92

Market Cap

899.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXF
FBRX
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
800.6M
899.4M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
FOXF
FBRX
Price
$21.85
$76.92
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$30.25
$67.00
AVG Volume (30 Days)
610.9K
2.1M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.30
EPS
N/A
N/A
Revenue
$1,467,321,000.00
$36,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.27
N/A
52 Week Low
$13.08
$10.18
52 Week High
$30.56
$77.20

Technical Indicators

Market Signals
Indicator
FOXF
FBRX
Relative Strength Index (RSI) 63.88 84.36
Support Level $17.33 $26.85
Resistance Level $22.09 $77.20
Average True Range (ATR) 0.93 0.10
MACD 0.08 -1.78
Stochastic Oscillator 93.61 95.46

Price Performance

Historical Comparison
FOXF
FBRX

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: